Top 10 Trending AI Stocks on Latest News

6. Tevogen Bio Holdings Inc. (NASDAQ:TVGN)

Number of Hedge Fund Holders: 10

Tevogen Bio Holdings Inc. (NASDAQ:TVGN) operates as a clinical-stage specialty immunotherapy company that develops off-the-shelf precision T-cell therapies for the treatment of infectious diseases, cancers, and neurological disorders. The company’s sentiments in the market have received a significant boost after announcing an expanded collaboration with tech giant Microsoft.

On January 28th, the biotech company confirmed that it is increasingly leveraging Microsoft AI and cloud capabilities to enhance the development of its proprietary technology, PredicTcell. With the help of Microsoft’s state-of-the-art AI, cloud computing, and health and life sciences domain expertise, this expanded partnership aims to strengthen Tevogen Bio Holdings Inc.’s (NASDAQ:TVGN) pipeline of novel immunotherapies by speeding up target identification and pre-clinical procedures. The partnership with Microsoft marks a significant turning point in Tevogen Bio’s quest to transform immunotherapy. The business will use AI to provide patients with more individualized and accurate treatments more quickly by working more closely with Microsoft domain experts.